section name header

Y-Site Injection Compatibility (1:1 Mixture)

Bivalirudin

(Mfr: TMC)(Conc: 5 mg/mLa)

I

Reteplase

(Mfr: CEN)(Conc: 1 unit/mLa)

Remarks:

Small aggregates form immediately

Ref:

2373